Skip to main content
. 2022 Oct 21;25(Suppl 6):e26009. doi: 10.1002/jia2.26009
Abstract P140 – Table 1. Demographics and quality of life reported by physician and PLWHIV.
QoL measures overall and by age Total 18 to 30 31 to 50 51 to 60 61 to 70 71 to 82
Length of time since diagnosis (years) n 489 66 260 103 48 12
mean 6.8 1.8 5.2 10.4 13.3 14.9
Physician‐reported quality of life n 600 82 311 132 62 13
Level of general bodily pain or discomfort because of their HIV (mean, 1 is no pain, 5 is extreme pain) mean 1.5 1.3 1.5 1.6 1.6 1.8
Level of general fatigue because of their HIV (mean, 1 is no fatigue, 5 is extreme fatigue) mean 1.8 1.7 1.8 1.8 1.8 1.9
Level of anxiety because of their HIV (mean, 1 is no anxiety, 5 is extreme anxiety) mean 1.8 1.7 1.8 1.8 1.8 2.2
PLWHIV‐reported quality of life n 249 29 131 57 26 6
Physical burden of taking HIV medication (1 = never, 5 = always) mean 1.7 1.8 1.8 1.6 1.6 1.3
Mental burden of taking HIV medication (1 = never, 5 = always) mean 2.0 2.0 2.1 1.8 1.8 1.5
Comfort about taking HIV medication in front of other people (1 = strongly disagree, 5 = strongly agree) mean 2.8 2.7 2.8 2.5 3.3 2.7
Concern about being dependent on medication (1 = strongly disagree, 5 = strongly agree) mean 3.2 3.0 3.3 3.1 3.4 2.3
PLWHIV‐reported PRO instruments
EQ‐5D VAS score n 241 29 126 55 25 6
mean 81.6 87.2 81.2 82.6 75.0 79.8
EQ‐5D 5L ‐ US n 235 29 124 51 25 6
mean 0.86 0.94 0.86 0.85 0.76 0.79
PozQoL overall QoL ‐ average score [1 to 5] n 248 29 131 56 26 6
mean 3.4 3.3 3.2 3.5 3.5 4.0
Physician‐ and PLWHIV‐reported treatment satisfaction
Physician‐stated treatment satisfaction (very satisfied) n 599 81 311 132 62 13
% 56% 54% 56% 58% 58% 69%
Patient‐stated treatment satisfaction (very satisfied) n 249 29 131 57 26 6
% 51% 48% 50% 47% 62% 100%

EQ‐5D 5L, EuroQol 5‐Dimension Health Questionnaire; EQ‐5D VAS, EuroQol 5‐Dimension Visual Analogue Scale; PRO, patient‐reported outcome; QoL, quality of life; US, United States.